Matyjek, A.; Rymarz, A.; Nowicka, Z.; Literacki, S.; Rozmyslowicz, T.; Niemczyk, S.
Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study. J. Clin. Med. 2021, 10, 5709.
https://doi.org/10.3390/jcm10235709
AMA Style
Matyjek A, Rymarz A, Nowicka Z, Literacki S, Rozmyslowicz T, Niemczyk S.
Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study. Journal of Clinical Medicine. 2021; 10(23):5709.
https://doi.org/10.3390/jcm10235709
Chicago/Turabian Style
Matyjek, Anna, Aleksandra Rymarz, Zuzanna Nowicka, Slawomir Literacki, Tomasz Rozmyslowicz, and Stanislaw Niemczyk.
2021. "Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study" Journal of Clinical Medicine 10, no. 23: 5709.
https://doi.org/10.3390/jcm10235709
APA Style
Matyjek, A., Rymarz, A., Nowicka, Z., Literacki, S., Rozmyslowicz, T., & Niemczyk, S.
(2021). Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome—A Single Center Prospective Study. Journal of Clinical Medicine, 10(23), 5709.
https://doi.org/10.3390/jcm10235709
